PT Medela Potentia Tbk
PT Medela Potentia Tbk distributes and markets pharmaceutical and healthcare products, and medical devices in Indonesia and Cambodia. It also manufactures medical devices, including consumables and medical equipment for hospitals and laboratories; and engages in the wholesale trade of laboratory equipment, pharmaceutical tools, and medical instruments for human use, as well as pharmaceutical prod… Read more
PT Medela Potentia Tbk (MDLA) - Net Assets
Latest net assets as of June 2025: Rp3.05 Trillion IDR
Based on the latest financial reports, PT Medela Potentia Tbk (MDLA) has net assets worth Rp3.05 Trillion IDR as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rp6.26 Trillion) and total liabilities (Rp3.21 Trillion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rp3.05 Trillion |
| % of Total Assets | 48.66% |
| Annual Growth Rate | 8.59% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 7.01 |
PT Medela Potentia Tbk - Net Assets Trend (2021–2024)
This chart illustrates how PT Medela Potentia Tbk's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for PT Medela Potentia Tbk (2021–2024)
The table below shows the annual net assets of PT Medela Potentia Tbk from 2021 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | Rp2.21 Trillion | +13.72% |
| 2023-12-31 | Rp1.94 Trillion | +13.85% |
| 2022-12-31 | Rp1.71 Trillion | -1.09% |
| 2021-12-31 | Rp1.72 Trillion | -- |
Equity Component Analysis
This analysis shows how different components contribute to PT Medela Potentia Tbk's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 29.9% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Rp1.94 Trillion | 90.52% |
| Common Stock | Rp210.00 Billion | 9.81% |
| Other Comprehensive Income | Rp-22.50 Billion | -1.05% |
| Other Components | Rp15.52 Billion | 0.72% |
| Total Equity | Rp2.14 Trillion | 100.00% |
PT Medela Potentia Tbk Competitors by Market Cap
The table below lists competitors of PT Medela Potentia Tbk ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
KWG PROPERTY (KOU.SG)
STU:KOU
|
$131.02 |
|
BANK OF BARODA UGANDA LTD
USE:BOBU
|
$131.16 |
|
Invest Capital Investment Bank Ltd
KAR:ICIBL
|
$131.42 |
|
Italpinas Development Corp
PSE:IDC
|
$131.49 |
|
DFNN Inc
PSE:DFNN
|
$130.46 |
|
EASTFIELD RES
BE:35E
|
$130.33 |
|
Innoveren Scientific Inc.
PINK:IVRN
|
$130.13 |
|
Unicap Modaraba
KAR:UCAPM
|
$130.12 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in PT Medela Potentia Tbk's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,881,227,000,000 to 2,140,531,000,000, a change of 259,304,000,000 (13.8%).
- Net income of 345,033,000,000 contributed positively to equity growth.
- Dividend payments of 115,000,000,000 reduced retained earnings.
- Other comprehensive income decreased equity by 22,501,000,000.
- Other factors increased equity by 51,772,000,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rp345.03 Billion | +16.12% |
| Dividends Paid | Rp115.00 Billion | -5.37% |
| Other Comprehensive Income | Rp-22.50 Billion | -1.05% |
| Other Changes | Rp51.77 Billion | +2.42% |
| Total Change | Rp- | 13.78% |
Book Value vs Market Value Analysis
This analysis compares PT Medela Potentia Tbk's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.00x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.76x to 1.00x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | Rp122.40 | Rp216.00 | x |
| 2022-12-31 | Rp117.09 | Rp216.00 | x |
| 2023-12-31 | Rp134.25 | Rp216.00 | x |
| 2024-12-31 | Rp216.46 | Rp216.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently PT Medela Potentia Tbk utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 16.12%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 2.37%
- • Asset Turnover: 2.54x
- • Equity Multiplier: 2.68x
- Recent ROE (16.12%) is below the historical average (17.54%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | 18.93% | 2.80% | 3.06x | 2.21x | Rp153.14 Billion |
| 2022 | 19.01% | 2.67% | 2.65x | 2.69x | Rp147.76 Billion |
| 2023 | 16.11% | 2.32% | 2.79x | 2.50x | Rp114.97 Billion |
| 2024 | 16.12% | 2.37% | 2.54x | 2.68x | Rp130.98 Billion |
Industry Comparison
This section compares PT Medela Potentia Tbk's net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $1,358,019,456,962
- Average return on equity (ROE) among peers: 6.27%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| PT Medela Potentia Tbk (MDLA) | Rp3.05 Trillion | 18.93% | 1.05x | $130.48 |
| Enseval Putra Megatrading Tbk (EPMT) | $5.13 Trillion | 10.09% | 0.45x | $31.13 Million |
| Itama Ranoraya (IRRA) | $512.31 Billion | 10.40% | 2.24x | $4.89 Million |
| Kimia Farma Persero Tbk (KAEF) | $947.76 Billion | 5.84% | 0.53x | $16.65 Million |
| Millennium Pharmacon International (SDPC) | $282.50 Billion | 5.99% | 5.27x | $1.76 Million |
| PT Soho Global Health Tbk (SOHO) | $1.21 Trillion | 4.10% | 1.31x | $138.50 Million |
| Dosni Roha Indonesia Tbk PT (ZBRA) | $69.73 Billion | 1.21% | 0.95x | $1.64 Million |